Keller Max, Bhadbhade Mohan M, Read Roger W
School of Chemistry, University of New South Wales, Sydney, NSW 2052, Australia.
Acta Crystallogr C. 2012 Jun;68(Pt 6):o240-6. doi: 10.1107/S0108270112019622. Epub 2012 May 19.
In two dibenzodiazepinones, viz. the tricyclic core structure, 5H-dibenzo[b,e]diazepin-11(10H)-one, C(13)H(10)N(2)O, and an acylated derivative, 1-(11-hydroxy-5H-dibenzo[b,e]diazepin-5-yl)-2-{4-[3-(1H-imidazol-1-yl)propyl]piperidin-1-yl}ethanone ethanol monosolvate, C(26)H(29)N(5)O(2)·C(2)H(5)OH, dimeric association via hydrogen-bond bridging between the cyclic amide entities is evident, but there are considerable differences between the parent compound and the amidated derivative. Highly consistent with reported structures of related tricyclic lactams, two molecules of the nonsubstituted compound are bridged through two N-H...O hydrogen bonds across a crystallographic centre of symmetry and the bond lengths of the cyclic amide entity correspond to the amino-oxo (lactam) tautomeric form. In contrast, the structure of the derivative shows two similar, but crystallographically unique, molecules hydrogen bonded into a dimeric unit exhibiting an approximate (noncrystallographic) C2 axis. The bond lengths of the two derivative cyclic amide groups support their potential presence in the hydroxyimine (lactim) tautomeric forms, with the resulting possibility of intermolecular tautomerism. Likely driving forces for the two extreme configurations are discussed.
在两种二苯并二氮杂䓬酮中,即三环核心结构5H-二苯并[b,e]二氮杂䓬-11(10H)-酮(C₁₃H₁₀N₂O)和一种酰化衍生物1-(11-羟基-5H-二苯并[b,e]二氮杂䓬-5-基)-2-{4-[3-(1H-咪唑-1-基)丙基]哌啶-1-基}乙酮乙醇单溶剂化物(C₂₆H₂₉N₅O₂·C₂H₅OH)中,通过环酰胺实体之间的氢键桥连形成二聚体缔合是明显的,但母体化合物和酰胺化衍生物之间存在相当大的差异。与相关三环内酰胺的报道结构高度一致,未取代化合物的两个分子通过两个N-H...O氢键跨过一个晶体学对称中心桥连,并且环酰胺实体的键长对应于氨基-氧代(内酰胺)互变异构形式。相比之下,衍生物的结构显示两个相似但晶体学上独特的分子通过氢键结合成一个具有近似(非晶体学)C₂轴的二聚体单元。两种衍生物环酰胺基团的键长支持它们可能以羟基亚胺(内酰亚胺)互变异构形式存在,从而产生分子间互变异构的可能性。讨论了这两种极端构型可能的驱动力。